METHODS FOR TREATING, PREVENTING, AND REDUCING THE RISK OF THE ONSET OF ALZHEIMER'S DISEASE USING AN HMG COA REDUCTASE INHIBITOR

摘要

Described are methods for treating, preventing, or reducing the risk of the onset of Alzheimer's disease by administering a therapeutically effective amount of an inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase ("HMG CoA reductase inhibitor") to a patient who is at risk for a coronary or cerebrovascular event or at risk for Alzheimer's disease.